Braskem S.A. (BAK)
NYSE: BAK
· Real-Time Price · USD
3.63
-0.32 (-8.10%)
At close: May 09, 2025, 3:59 PM
3.55
-2.20%
After-hours: May 09, 2025, 05:05 PM EDT
Braskem S.A. Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Benzene Toluene And Xylene Revenue | 4.97B |
| Benzene Toluene And Xylene Revenue Growth | n/a |
| Butadiene Revenue | 1.94B |
| Butadiene Revenue Growth | n/a |
| Cumene Revenue | 1.33B |
| Cumene Revenue Growth | n/a |
| Ethylene Propylene Revenue | 4.79B |
| Ethylene Propylene Revenue Growth | n/a |
| Other 1 Revenue | 2.74B |
| Other 1 Revenue Growth | n/a |
| Solvents Revenue | 619M |
| Solvents Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.31B | 1.17B | 936M | 1.16B | 1.19B | 1.1B | 1.05B | 1.09B | 1.33B | 1.2B | 1.18B | 1.16B | 1.35B | 1.19B | 1.05B | 991M | 1.07B | 928M | 872M | 904.4M | 1.15B | 1.01B | 936M | 931.76M | 963M | 859.16M | 680.37M | 676.35M | 813.9M | 753.01M | 670.11M | 656.87M | 840M | 769.34M | 729.1M | 668.59M | 768M | 616.45M | 560.25M | 559.02M |
| Selling, General, and Administrative Revenue Growth | +12.21% | +25.11% | -18.96% | -2.56% | +7.46% | +4.75% | -3.66% | -18.13% | +11.25% | +2.04% | +1.20% | -13.99% | +13.82% | +13.16% | +5.85% | -7.12% | +14.98% | +6.42% | -3.58% | -21.14% | +13.34% | +8.10% | +0.45% | -3.24% | +12.09% | +26.28% | +0.60% | -16.90% | +8.09% | +12.37% | +2.02% | -21.80% | +9.18% | +5.52% | +9.05% | -12.94% | +24.59% | +10.03% | +0.22% | n/a |
| Research and Development Revenue | 143M | 109M | 106M | 106M | 115.86M | 92M | 81M | 94M | 119M | 104M | 78M | 73M | 99M | 74M | 62M | 62M | 78M | 63M | 54M | 55.5M | 78.2M | 58.66M | 52M | 48.98M | 61M | 53.08M | 46.75M | 38.93M | 56.47M | 38.84M | 38.48M | 33.66M | 42M | 37.22M | 40.03M | 42.59M | 49.76M | 37.72M | 42.34M | 39.82M |
| Research and Development Revenue Growth | +31.19% | +2.83% | 0.00% | -8.51% | +25.94% | +13.58% | -13.83% | -21.01% | +14.42% | +33.33% | +6.85% | -26.26% | +33.78% | +19.35% | 0.00% | -20.51% | +23.81% | +16.67% | -2.70% | -29.03% | +33.32% | +12.80% | +6.17% | -19.71% | +14.93% | +13.53% | +20.10% | -31.07% | +45.40% | +0.93% | +14.32% | -19.85% | +12.85% | -7.03% | -6.01% | -14.40% | +31.93% | -10.91% | +6.33% | n/a |
| Sales and Marketing Revenue | 555M | 530M | 447M | 459M | 525M | 418M | 495M | 477M | 536M | 515M | 510M | 548M | 580M | 544M | 460M | 472M | 482M | 482M | 448M | 439.9M | 453.46M | 437.96M | 436M | 431.08M | 446M | 433.48M | 298.79M | 367.52M | 374.14M | 380.88M | 358.28M | 346.3M | 393M | 376.29M | 355.54M | 319.88M | 306M | 293.78M | 260.47M | 261.92M |
| Sales and Marketing Revenue Growth | +4.72% | +18.57% | -2.61% | -12.57% | +25.60% | -15.56% | +3.77% | -11.01% | +4.08% | +0.98% | -6.93% | -5.52% | +6.62% | +18.26% | -2.54% | -2.07% | 0.00% | +7.59% | +1.84% | -2.99% | +3.54% | +0.45% | +1.14% | -3.35% | +2.89% | +45.08% | -18.70% | -1.77% | -1.77% | +6.31% | +3.46% | -11.88% | +4.44% | +5.84% | +11.15% | +4.53% | +4.16% | +12.79% | -0.56% | n/a |